Effects of one-year supplementation with Phyllanthus niruri on fibrosis score and metabolic markers in patients with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled trial

[1]  C. Bammigatti,et al.  Efficacy of Phyllanthus niruri on improving liver functions in patients with alcoholic hepatitis: A double-blind randomized controlled trial , 2021, Indian journal of pharmacology.

[2]  L. N. Valenti,et al.  Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: a systematic review and meta-analysis. , 2021, Journal of hepatology.

[3]  C. Bonfiglio,et al.  Physical Activity and Low Glycemic Index Mediterranean Diet: Main and Modification Effects on NAFLD Score. Results from a Randomized Clinical Trial , 2020, Nutrients.

[4]  A. Ruiz-Margáin,et al.  Clinical assessment and management of liver fibrosis in non-alcoholic fatty liver disease , 2020, World journal of gastroenterology.

[5]  R. Rector,et al.  A Fad too Far? Dietary Strategies for the Prevention and Treatment of NAFLD , 2020, Obesity.

[6]  C. Valério,et al.  NAFLD as a continuum: from obesity to metabolic syndrome and diabetes , 2020, Diabetology & Metabolic Syndrome.

[7]  S. Softic,et al.  Evolving Role for Pharmacotherapy in NAFLD/NASH , 2020, Clinical and translational science.

[8]  Yameng Sun,et al.  Regression of liver fibrosis: evidence and challenges , 2020, Chinese medical journal.

[9]  S. Ezzat,et al.  In-depth hepatoprotective mechanistic study of Phyllanthus niruri: In vitro and in vivo studies and its chemical characterization , 2020, PLoS ONE.

[10]  F. Donato,et al.  Phyllanthus niruri versus Placebo for Chronic Hepatitis B Virus Infection: A Randomized Controlled Trial , 2018, Complementary Medicine Research.

[11]  L. Bolondi,et al.  Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis , 2018, World journal of gastroenterology.

[12]  G. Kaur,et al.  Adipocytokine Regulation and Antiangiogenic Activity Underlie the Molecular Mechanisms of Therapeutic Effects of Phyllanthus niruri against Non-Alcoholic Fatty Liver Disease , 2018, Nutrients.

[13]  T. Yamanaka,et al.  Efficacy of glutathione for the treatment of nonalcoholic fatty liver disease: an open-label, single-arm, multicenter, pilot study , 2017, BMC Gastroenterology.

[14]  G. Kaur,et al.  Phyllanthus Niruri Standardized Extract Alleviates the Progression of Non-Alcoholic Fatty Liver Disease and Decreases Atherosclerotic Risk in Sprague–Dawley Rats , 2017, Nutrients.

[15]  S. A. Soelar,et al.  Efficacy and Safety of Phyllanthus Niruri in Non-alcoholic Steatohepatitis Treatment: Pilot Study from Malaysia , 2017 .

[16]  Xuchen Zhang,et al.  Non-alcoholic fatty liver disease: An expanded review , 2017, World journal of hepatology.

[17]  M. Trauner,et al.  A prospective study to evaluate the efficacy of a standardized low calorie diet (HEPAFAST®) according to PNPLA3 genotype in patients with Non Alcoholic Fatty Liver Disease (NAFLD) – 2 months data (interim analysis) , 2017, Zeitschrift für Gastroenterologie.

[18]  E. Rhee,et al.  Lobeglitazone, a Novel Thiazolidinedione, Improves Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes: Its Efficacy and Predictive Factors Related to Responsiveness , 2016, Journal of Korean medical science.

[19]  K. Jeevaratnam,et al.  The pharmacological potential of Phyllanthus niruri , 2016, The Journal of pharmacy and pharmacology.

[20]  L. Henry,et al.  Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes , 2016, Hepatology.

[21]  C. Stokes,et al.  Effect of Short-Term Vitamin D Correction on Hepatic Steatosis as Quantified by Controlled Attenuation Parameter (CAP). , 2016, Journal of gastrointestinal and liver diseases : JGLD.

[22]  S. Alavian,et al.  Ginger Supplementation in Nonalcoholic Fatty Liver Disease: A Randomized, Double-Blind, Placebo-Controlled Pilot Study , 2016, Hepatitis monthly.

[23]  T. Kisseleva,et al.  Reversibility of liver fibrosis. , 2015, Clinics and research in hepatology and gastroenterology.

[24]  G. Elpek.  Angiogenesis and liver fibrosis. , 2015, World journal of hepatology.

[25]  S. Adjei,et al.  Acute toxicity studies of aqueous leaf extract of phyllanthus niruri , 2011 .

[26]  O. Salawu,et al.  The Anti-Inflammatory and Antinociceptive Properties of the Chloroform Fraction From Phyllanthus niruri Plant Is Mediated via the Peripheral Nervous System , 2010, Journal of dietary supplements.

[27]  Jang-woo Shin,et al.  Interpretation of Animal Dose and Human Equivalent Dose for Drug Development , 2010 .

[28]  P. Bag,et al.  Effect of Phyllanthus niruri Linn. treatment on liver, kidney and testes in CCl4 induced hepatotoxic rats. , 2008, Indian journal of experimental biology.

[29]  Philippe Giral,et al.  Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) Trial. , 2008, Gastroenterology.

[30]  P. Sil,et al.  Protein isolate from the herb, Phyllanthus niruri L. (Euphorbiaceae), plays hepatoprotective role against carbon tetrachloride induced liver damage via its antioxidant properties. , 2007, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[31]  Yoosoo Chang,et al.  Higher concentrations of alanine aminotransferase within the reference interval predict nonalcoholic fatty liver disease. , 2007, Clinical chemistry.

[32]  J. Stanslas,et al.  Phytochemicals from Phyllanthus niruri Linn. and their pharmacological properties: a review , 2006, The Journal of pharmacy and pharmacology.

[33]  P. Sil,et al.  Hepatoprotective effect of aqueous extract of Phyllanthus niruri on nimesulide-induced oxidative stress in vivo. , 2006, Indian journal of biochemistry & biophysics.

[34]  P. Sil,et al.  The protein fraction of Phyllanthus niruri plays a protective role against acetaminophen induced hepatic disorder via its antioxidant properties , 2006, Phytotherapy research : PTR.

[35]  I. Millman,et al.  Effects of an extract from Phyllanthus niruri on hepatitis B and woodchuck hepatitis viruses: in vitro and in vivo studies. , 1987, Proceedings of the National Academy of Sciences of the United States of America.